Related references
Note: Only part of the references are listed.Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer
Meng-Hang Yang et al.
MOLECULAR BIOLOGY REPORTS (2022)
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study
Wenxian Wang et al.
LUNG CANCER (2021)
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
Jessica J. Lin et al.
NPJ PRECISION ONCOLOGY (2020)
Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade
Ke-Jie Chang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases
Wade T. Iams et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Combined small-cell lung carcinoma
Jing Qin et al.
ONCOTARGETS AND THERAPY (2018)
Non-small cell to small cell lung cancer on PD-I inhibitors: two cases on potential histologic transformation
Nadine Abdallah et al.
LUNG CANCER-TARGETS AND THERAPY (2018)
CARE guidelines for case reports: explanation and elaboration document
David S. Riley et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
June-Koo Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation
Eric Santoni-Rugiu et al.
LUNG CANCER (2017)
Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
Takuma Imakita et al.
RESPIRATORY MEDICINE CASE REPORTS (2017)
Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors
Delphine Levacq et al.
LUNG CANCER (2016)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst et al.
NATURE COMMUNICATIONS (2015)
Alveolar progenitor and stem cells in lung development, renewal and cancer
Tushar J. Desai et al.
NATURE (2014)
Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma
Sara Mainardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma
Kate D. Sutherland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
Kate D. Sutherland et al.
CANCER CELL (2011)
Characterization of the cell of origin for small cell lung cancer
Kwon-Sik Park et al.
CELL CYCLE (2011)
EGFR mutations in small-cell lung cancers in patients who have never smoked
MF Zakowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
